Usman Salis
⬤ Hims & Hers Health (HIMS) dropped below the critical $30 support zone on the weekly chart, confirming a breakdown that's letting bears take control. The stock couldn't hold this level, and now the downward pressure is building after weeks of declining prices.
⬤ Looking at the bigger picture, HIMS was riding a solid uptrend from 2023 through early 2025, backed by climbing moving averages and steadily higher peaks. But recent weekly candles tell a different story—the price rolled over and closed under the $30 mark that had been keeping it afloat. This breakdown matches up with the weakening trend that's been developing as selling pressure gradually picked up steam.
⬤ With $30 in the rearview mirror, traders are eyeing the $25 zone as the next potential landing spot—it lines up with where the stock consolidated before. Meanwhile, resistance levels sit way above current action at $67, $100, and even $140, showing just how far HIMS has fallen from its earlier highs.
⬤ Losing weekly support matters for anyone tracking momentum in growth stocks. When a stock gives up a long-held support level after a big rally, it usually means something's shifted in both momentum and investor sentiment. How HIMS handles these lower price levels will determine whether this turns into a deeper pullback or finds its footing in a new range.
Usman Salis
